 | • レポートコード：MRC23Q36325 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の腎代替療法市場について調査・分析し、世界の腎代替療法市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（機器、ダイアライザー、その他消耗品、サービス）、用途別セグメント分析（病院、透析センター、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Fresenius、DaVita、Baxter、US rental care、B.Braun、Diaverum、Nipro、Asahi Kasei、Nikkiso、Toray、WEGO、JMS、Medtronic、SWS Hemodialysis Care、DIALIFE SAなどが含まれています。世界の腎代替療法市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、腎代替療法市場規模を推定する際に考慮しました。本レポートは、腎代替療法の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、腎代替療法に関するビジネス上の意思決定に役立てることを目的としています。 ・腎代替療法市場の概要 - 腎代替療法のタイプ別セグメント - 世界の腎代替療法市場規模：タイプ別分析（機器、ダイアライザー、その他消耗品、サービス） - 腎代替療法の用途別セグメント - 世界の腎代替療法市場規模：用途別分析（病院、透析センター、その他） - 世界の腎代替療法市場規模予測（2018年-2029年） ・腎代替療法市場の成長トレンド - 腎代替療法の地域別市場規模（2018年-2029年） - 腎代替療法市場ダイナミクス - 腎代替療法の業界動向 - 腎代替療法市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：機器、ダイアライザー、その他消耗品、サービス - 世界の腎代替療法のタイプ別市場規模（2018年-2023年） - 世界の腎代替療法のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、透析センター、その他 - 世界の腎代替療法の用途別市場規模（2018年-2023年） - 世界の腎代替療法の用途別市場規模（2024年-2029年） ・腎代替療法の地域別市場規模 - 北米の腎代替療法市場規模（2018年-2029年） - アメリカの腎代替療法市場規模（2018年-2029年） - ヨーロッパの腎代替療法市場規模（2018年-2029年） - アジア太平洋の腎代替療法市場規模（2018年-2029年） - 中国の腎代替療法市場規模（2018年-2029年） - 日本の腎代替療法市場規模（2018年-2029年） - 韓国の腎代替療法市場規模（2018年-2029年） - インドの腎代替療法市場規模（2018年-2029年） - オーストラリアの腎代替療法市場規模（2018年-2029年） - 中南米の腎代替療法市場規模（2018年-2029年） - 中東・アフリカの腎代替療法市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Fresenius、DaVita、Baxter、US rental care、B.Braun、Diaverum、Nipro、Asahi Kasei、Nikkiso、Toray、WEGO、JMS、Medtronic、SWS Hemodialysis Care、DIALIFE SA ・アナリストの観点/結論 ・調査方法とデータソース |
Renal replacement therapy (RRT) is therapy that replaces the normal blood-filtering function of the kidneys. It is used when the kidneys are not working well, which is called kidney failure and includes acute kidney injury and chronic kidney disease. Renal replacement therapy includes dialysis (hemodialysis or peritoneal dialysis), hemofiltration, and hemodiafiltration, which are various ways of filtration of blood with or without machines. Renal replacement therapy also includes kidney transplantation, which is the ultimate form of replacement in that the old kidney is replaced by a donor kidney.
Highlights
The global Renal Replacement Therapy market was valued at US$ 99080 million in 2022 and is anticipated to reach US$ 129690 million by 2029, witnessing a CAGR of 4.6% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Fresenius is one of the most important global key players of the renal replacement therapy, holds about 20% of shares of the global renal replacement therapy market, other key players include DaVita, Baxter, etc. North America is the largest market, occupied for about 40 percent, followed by the Asia Pacific. In terms of type, services is the largest segment, with a share of over 80%, and in terms of end user, the dialysis center segment holds a share of over 60 percent.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Renal Replacement Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Replacement Therapy.
The Renal Replacement Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Renal Replacement Therapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Renal Replacement Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Fresenius
DaVita
Baxter
US rental care
B.Braun
Diaverum
Nipro
Asahi Kasei
Nikkiso
Toray
WEGO
JMS
Medtronic
SWS Hemodialysis Care
DIALIFE SA
Segment by Type
Devices
Dialyzer
Other Consumables
Services
Segment by Application
Hospital
Dialysis Center
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Renal Replacement Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Replacement Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Devices
1.2.3 Dialyzer
1.2.4 Other Consumables
1.2.5 Services
1.3 Market by Application
1.3.1 Global Renal Replacement Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Dialysis Center
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Renal Replacement Therapy Market Perspective (2018-2029)
2.2 Renal Replacement Therapy Growth Trends by Region
2.2.1 Global Renal Replacement Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Renal Replacement Therapy Historic Market Size by Region (2018-2023)
2.2.3 Renal Replacement Therapy Forecasted Market Size by Region (2024-2029)
2.3 Renal Replacement Therapy Market Dynamics
2.3.1 Renal Replacement Therapy Industry Trends
2.3.2 Renal Replacement Therapy Market Drivers
2.3.3 Renal Replacement Therapy Market Challenges
2.3.4 Renal Replacement Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Renal Replacement Therapy Players by Revenue
3.1.1 Global Top Renal Replacement Therapy Players by Revenue (2018-2023)
3.1.2 Global Renal Replacement Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Renal Replacement Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Renal Replacement Therapy Revenue
3.4 Global Renal Replacement Therapy Market Concentration Ratio
3.4.1 Global Renal Replacement Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Replacement Therapy Revenue in 2022
3.5 Renal Replacement Therapy Key Players Head office and Area Served
3.6 Key Players Renal Replacement Therapy Product Solution and Service
3.7 Date of Enter into Renal Replacement Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Replacement Therapy Breakdown Data by Type
4.1 Global Renal Replacement Therapy Historic Market Size by Type (2018-2023)
4.2 Global Renal Replacement Therapy Forecasted Market Size by Type (2024-2029)
5 Renal Replacement Therapy Breakdown Data by Application
5.1 Global Renal Replacement Therapy Historic Market Size by Application (2018-2023)
5.2 Global Renal Replacement Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Renal Replacement Therapy Market Size (2018-2029)
6.2 North America Renal Replacement Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Renal Replacement Therapy Market Size by Country (2018-2023)
6.4 North America Renal Replacement Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Renal Replacement Therapy Market Size (2018-2029)
7.2 Europe Renal Replacement Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Renal Replacement Therapy Market Size by Country (2018-2023)
7.4 Europe Renal Replacement Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Renal Replacement Therapy Market Size (2018-2029)
8.2 Asia-Pacific Renal Replacement Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Renal Replacement Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Renal Replacement Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Renal Replacement Therapy Market Size (2018-2029)
9.2 Latin America Renal Replacement Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Renal Replacement Therapy Market Size by Country (2018-2023)
9.4 Latin America Renal Replacement Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Renal Replacement Therapy Market Size (2018-2029)
10.2 Middle East & Africa Renal Replacement Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Renal Replacement Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Renal Replacement Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fresenius
11.1.1 Fresenius Company Detail
11.1.2 Fresenius Business Overview
11.1.3 Fresenius Renal Replacement Therapy Introduction
11.1.4 Fresenius Revenue in Renal Replacement Therapy Business (2018-2023)
11.1.5 Fresenius Recent Development
11.2 DaVita
11.2.1 DaVita Company Detail
11.2.2 DaVita Business Overview
11.2.3 DaVita Renal Replacement Therapy Introduction
11.2.4 DaVita Revenue in Renal Replacement Therapy Business (2018-2023)
11.2.5 DaVita Recent Development
11.3 Baxter
11.3.1 Baxter Company Detail
11.3.2 Baxter Business Overview
11.3.3 Baxter Renal Replacement Therapy Introduction
11.3.4 Baxter Revenue in Renal Replacement Therapy Business (2018-2023)
11.3.5 Baxter Recent Development
11.4 US rental care
11.4.1 US rental care Company Detail
11.4.2 US rental care Business Overview
11.4.3 US rental care Renal Replacement Therapy Introduction
11.4.4 US rental care Revenue in Renal Replacement Therapy Business (2018-2023)
11.4.5 US rental care Recent Development
11.5 B.Braun
11.5.1 B.Braun Company Detail
11.5.2 B.Braun Business Overview
11.5.3 B.Braun Renal Replacement Therapy Introduction
11.5.4 B.Braun Revenue in Renal Replacement Therapy Business (2018-2023)
11.5.5 B.Braun Recent Development
11.6 Diaverum
11.6.1 Diaverum Company Detail
11.6.2 Diaverum Business Overview
11.6.3 Diaverum Renal Replacement Therapy Introduction
11.6.4 Diaverum Revenue in Renal Replacement Therapy Business (2018-2023)
11.6.5 Diaverum Recent Development
11.7 Nipro
11.7.1 Nipro Company Detail
11.7.2 Nipro Business Overview
11.7.3 Nipro Renal Replacement Therapy Introduction
11.7.4 Nipro Revenue in Renal Replacement Therapy Business (2018-2023)
11.7.5 Nipro Recent Development
11.8 Asahi Kasei
11.8.1 Asahi Kasei Company Detail
11.8.2 Asahi Kasei Business Overview
11.8.3 Asahi Kasei Renal Replacement Therapy Introduction
11.8.4 Asahi Kasei Revenue in Renal Replacement Therapy Business (2018-2023)
11.8.5 Asahi Kasei Recent Development
11.9 Nikkiso
11.9.1 Nikkiso Company Detail
11.9.2 Nikkiso Business Overview
11.9.3 Nikkiso Renal Replacement Therapy Introduction
11.9.4 Nikkiso Revenue in Renal Replacement Therapy Business (2018-2023)
11.9.5 Nikkiso Recent Development
11.10 Toray
11.10.1 Toray Company Detail
11.10.2 Toray Business Overview
11.10.3 Toray Renal Replacement Therapy Introduction
11.10.4 Toray Revenue in Renal Replacement Therapy Business (2018-2023)
11.10.5 Toray Recent Development
11.11 WEGO
11.11.1 WEGO Company Detail
11.11.2 WEGO Business Overview
11.11.3 WEGO Renal Replacement Therapy Introduction
11.11.4 WEGO Revenue in Renal Replacement Therapy Business (2018-2023)
11.11.5 WEGO Recent Development
11.12 JMS
11.12.1 JMS Company Detail
11.12.2 JMS Business Overview
11.12.3 JMS Renal Replacement Therapy Introduction
11.12.4 JMS Revenue in Renal Replacement Therapy Business (2018-2023)
11.12.5 JMS Recent Development
11.13 Medtronic
11.13.1 Medtronic Company Detail
11.13.2 Medtronic Business Overview
11.13.3 Medtronic Renal Replacement Therapy Introduction
11.13.4 Medtronic Revenue in Renal Replacement Therapy Business (2018-2023)
11.13.5 Medtronic Recent Development
11.14 SWS Hemodialysis Care
11.14.1 SWS Hemodialysis Care Company Detail
11.14.2 SWS Hemodialysis Care Business Overview
11.14.3 SWS Hemodialysis Care Renal Replacement Therapy Introduction
11.14.4 SWS Hemodialysis Care Revenue in Renal Replacement Therapy Business (2018-2023)
11.14.5 SWS Hemodialysis Care Recent Development
11.15 DIALIFE SA
11.15.1 DIALIFE SA Company Detail
11.15.2 DIALIFE SA Business Overview
11.15.3 DIALIFE SA Renal Replacement Therapy Introduction
11.15.4 DIALIFE SA Revenue in Renal Replacement Therapy Business (2018-2023)
11.15.5 DIALIFE SA Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details